La corretta regolazione o taratura obbligatoria della macchina irroratrice
Le aziende agricole lombarde del Parco Adda Sud protagoniste delle azioni dimostrative del progetto Trainagro
Ritorna il ciclo di workshop sulla Responsabilità Sociale d’Impresa - Workshops on Corporate Social Responsibility
Editorials & newsletterscontact us
|If you have any comments or you would like to share your point of view with us please email please contact a member of our staff|
HEROIC (Health and Environmental Risks: Organisation, Integration and Cross-fertilisation of Scientific Knowledge) is a multi-partner coordination action project between 9 institutions from seven EU countries, funded by the European Commission under the 7th Framework Programme, started in October. The coordinator is SCHAT the Swiss Center for Human Applied Toxicology of the University of Basel.
Its main objective is the improvement and harmonisation of tools and methods used for human and environmental risk assessment (RA) of chemicals of different classes (pesticides, biocides, pharmaceuticals, cosmetics, industrial chemicals), by exploring how data generated in the two disciplines of human and environmental toxicology can be applied across disciplines for integrated RA, developing a framework for integrated methodologies and approaches for RA.
Since the beginning of the project OPERA is involved in the communication and dissemination actions; later on OPERA’s involvement will be extended also to the development of the capacity building tools emerging from the expert work chaired by the other partners.
In October OPERA’s offices have hosted the kick off meeting of the project, later on they will be the stage for the stakeholder survey in March 2013.
Experts and stakeholders meetings are indeed the crucial appointments to make the project fruitfully progressing towards its objective: they will see the participation of risk assessment experts on the main issues of hazard and exposure assessment and mixture toxicity, belonging to government, NGOs, academia and industry, and of the different stakeholders in the RA value chain.
For further information please click here.